April 2, 2024

Blue Wolf Capital to Acquire Recipharm’s CDMO OSD Sites

NEW YORK, April 2, 2024–Blue Wolf Capital Partners LLC (“Blue Wolf”), a middle-market personal equity firm targeting the commercial and healthcare sectors, announced that it has committed, subject to regulatory approvals, to obtain seven Production and Progression Facilities: Solna, Stängnäs, Höganäs, Karlskoga, and Uppsala OTC Development in Sweden, Pessac in France and Parets in Spain, from Recipharm, a contract production and progression organization (“CDMO”)

Blue Wolf Capital to Acquire Recipharm’s CDMO OSD Sites Read More »